Telesis Bio Inc (TBIO)
0.91
+0.01
(+1.11%)
USD |
OTCM |
Nov 22, 12:45
Telesis Bio Enterprise Value: 27.14M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 27.14M |
| November 20, 2024 | 27.14M |
| November 19, 2024 | 27.23M |
| November 18, 2024 | 27.23M |
| November 15, 2024 | 27.20M |
| November 14, 2024 | 27.18M |
| November 13, 2024 | 27.26M |
| November 12, 2024 | 27.16M |
| November 11, 2024 | 27.17M |
| November 08, 2024 | 27.80M |
| November 07, 2024 | 27.50M |
| November 06, 2024 | 27.78M |
| November 05, 2024 | 27.81M |
| November 04, 2024 | 27.81M |
| November 01, 2024 | 27.97M |
| October 31, 2024 | 27.96M |
| October 30, 2024 | 28.20M |
| October 29, 2024 | 28.29M |
| October 28, 2024 | 28.29M |
| October 25, 2024 | 28.24M |
| October 24, 2024 | 28.56M |
| October 23, 2024 | 28.82M |
| October 22, 2024 | 29.37M |
| October 21, 2024 | 29.36M |
| October 18, 2024 | 30.14M |
| Date | Value |
|---|---|
| October 17, 2024 | 30.07M |
| October 16, 2024 | 30.15M |
| October 15, 2024 | 30.42M |
| October 14, 2024 | 30.47M |
| October 11, 2024 | 30.60M |
| October 10, 2024 | 30.42M |
| October 09, 2024 | 29.85M |
| October 08, 2024 | 29.53M |
| October 07, 2024 | 29.18M |
| October 04, 2024 | 30.07M |
| October 03, 2024 | 30.83M |
| October 02, 2024 | 31.17M |
| October 01, 2024 | 31.48M |
| September 30, 2024 | 32.34M |
| September 27, 2024 | 31.27M |
| September 26, 2024 | 32.62M |
| September 25, 2024 | 29.66M |
| September 24, 2024 | 30.35M |
| September 23, 2024 | 31.87M |
| September 20, 2024 | 31.02M |
| September 19, 2024 | 30.74M |
| September 18, 2024 | 27.96M |
| September 17, 2024 | 28.03M |
| September 16, 2024 | 28.29M |
| September 13, 2024 | 28.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.537M
Minimum
Jun 29 2022
594.55M
Maximum
Jun 22 2021
77.03M
Average
32.62M
Median
Sep 26 2024
Enterprise Value Benchmarks
| Standard BioTools Inc | 291.94M |
| Ainos Inc | 13.27M |
| Zomedica Corp | 51.69M |
| LENSAR Inc | 68.45M |
| Intelligent Bio Solutions Inc | 3.549M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.58M |
| Revenue (Quarterly) | 1.55M |
| Total Expenses (Quarterly) | 12.02M |
| EPS Diluted (Quarterly) | -7.62 |
| Gross Profit Margin (Quarterly) | -51.55% |
| Profit Margin (Quarterly) | -811.9% |
| Earnings Yield | -3.38K% |
| Normalized Earnings Yield | -2682.54 |